Diseases that primarily affect populations in low- and middle-income countries (LMICs) have a substantial toll on human health. Annually, more than one billion people are affected by a World Health ...
1d
DiMe introduces core digital measures set to accelerate drug development for pediatric rare diseases
The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) today announced the ...
A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.
Pharmaceutical Technology on MSN
Repertoire and Lilly join hands on autoimmune disease therapies
The agreement grants Repertoire an upfront payment of $85m, with the possibility of up to $1.84bn in additional milestone payments.
Mwila Mulubwa is an investigator in the drug metabolism and pharmacokinetics team at the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, South Africa. Leon Mutesa is a ...
These actions had an immediate chilling effect on mRNA research and development in the U.S., Coller told Live Science. And then, in August, HHS canceled nearly half a billion dollars of investment ...
Some 200 rare disease therapies are at risk of losing eligibility for a pediatric priority review voucher, a recent analysis ...
8don MSN
Gut bacteria may be linked to memory decline in mild cognitive impairment and Alzheimer's disease
A comprehensive new review is shedding light on the growing evidence that gut microbiome imbalances—known as dysbiosis—may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results